BSE filing, NSE: SAYAJIIND. Summary written from the filing by ALFA Finder's alert engine.
Sayaji Industries Ltd: key numbers
- Share price
- ₹109.50
- Market cap
- ₹276.8 Cr
- Revenue (annual)
- ₹1,072 Cr
- Net profit (annual)
- ₹1.37 Cr
- P/E (TTM)
- 11.1×Sector 26.8×
- Promoter holding
- 74.95%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sayaji Industries Ltd
All →Sayaji Industries Other Announcement
Sayaji Industries updated KMP contact details (phone and email) for MD and CEO per Reg 30(5) LODR. No business, financial, or strategic substance is disclosed.
Sayaji Industries Management Change
Sayaji Industries' Company Secretary & Compliance Officer Mr. Vishnu H Thaker resigned, effective 26 October 2026. He ceases to be Key Managerial Personnel from the close of business that day.
Sayaji Industries Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue ₹264 Cr (+6% YoY, -9% QoQ), EBITDA ₹16 Cr at 6.2% margin, PAT ₹3 Cr versus prior-year loss of ₹9 Cr. Margins compressed on input costs.
Sayaji Industries Results Update
Sayaji Industries reported Q2FY27 revenue of ₹264 Cr and PAT of ₹3.1 Cr. The MD noted a ₹73 Cr land divestment and upcoming JV project timelines.
Sayaji Industries Q2 FY27 Results: Turns Profitable, Net Profit ₹3.1 Cr
Sayaji Industries Ltd reported revenue from operations of ₹263.5 Cr (+5.7% YoY) and net profit of ₹3.1 Cr for Q2 FY27.
- Key figure
- Net profit ₹3.1 Cr
Sayaji Industries Merger & Restructuring Worth ₹73 Cr
Sayaji Industries sold 63,787 sqm of idle land in Ahmedabad to a third party for ₹73 Crore. The conveyance deed was executed on 19 October 2026.
- Value
- ₹73.00 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.